clonidine has been researched along with methylphenidate in 107 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (9.35) | 18.7374 |
1990's | 23 (21.50) | 18.2507 |
2000's | 35 (32.71) | 29.6817 |
2010's | 32 (29.91) | 24.3611 |
2020's | 7 (6.54) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahman, M; Holmén, AG; Wan, H | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Greenhill, LL | 1 |
Hart, LL; Hart-Santora, D | 1 |
Clemente, E; Giron, GP; Micaglio, M; Pigato, P; Pizzirani, E; Rizzoli, G; Thiener, A | 1 |
Buitelaar, JK; van der Gaag, RJ | 1 |
Zetler, G | 1 |
Clark, CR; Geffen, GM; Geffen, LB | 2 |
Bamford, KA; Caine, ED; Chiverton, P; McBride, MC; Rediess, S; Shiao, J | 1 |
Ferron, A; Lacroix, D | 1 |
Cohen, DJ; Hunt, RD; Minderaa, RB | 1 |
Hunt, RD | 1 |
Hasselager, E; Scheel-Krüger, J | 1 |
Cohen, DJ; Hunt, RD; Shaywitz, BA; Shaywitz, SE | 1 |
Anderson, G; Clark, L; Cohen, DJ; Hunt, RD | 1 |
Maloney, MJ; Schwam, JS | 1 |
Kwasman, A; Lepper, HS; Tinsley, BJ | 1 |
Biederman, J; Connor, D; Spencer, T; Wilens, TE; Wozniak, J | 1 |
Riddle, MA; Scahill, LD; Walkup, JT | 1 |
Harbison, RD; James, RC; Roberts, SM; Roth, L | 1 |
Mandoki, MW; Schvehla, TJ; Sumner, GS | 1 |
Fargason, RE; Ford, CV | 1 |
Licamele, WL; Rubinstein, S; Silver, LB | 1 |
Gunning, WB | 1 |
Blackman, JA; Gutgesell, H; Samson-Fang, L | 1 |
O'Malley, KD | 1 |
Popper, CW | 1 |
Chopin, P; Colpaert, FC; Marien, M | 1 |
Gunning, B; Stemerdink, N; van der Meere, J | 1 |
Cantwell, D; Connor, DF; Spencer, TJ; Swanson, JM; Wilens, TE | 1 |
Elia, J; Rowan, A; Weller, EB; Weller, RA | 1 |
Blackshaw, AJ; Crowley, C; Deakin, JF; Hawtin, K; Hopwood, A; Matthews, K; Middleton, HC; Robbins, TW; Rogers, RD; Sahakian, BJ; Wallace, C | 1 |
Dech, B | 1 |
Barkley, RA; Connor, DF; Davis, HT | 1 |
Miller, JL | 1 |
Kalb, C | 1 |
Vallée, L | 1 |
Aeckerlin, LP; Buitelaar, JK; Kooij, JJ | 1 |
Gianarris, WJ; Golden, CJ; Greene, L | 1 |
Baghurst, PA; Clark, JJ; Graetz, BW; Rey, JM; Sawyer, MG | 1 |
Joughin, C; Ramchandani, P; Zwi, M | 3 |
Robbins, TW | 1 |
McDougle, CJ; Posey, D | 1 |
Levenson, D | 1 |
Akasu, T; Ishimatsu, M; Kidani, Y; Kuwahata, T | 1 |
Biederman, J; Spencer, T; Wilens, T | 1 |
Reeves, G; Schweitzer, J | 1 |
Cummings, MR; Miller, BD | 1 |
McDougle, CJ | 1 |
Friemoth, J; Johnson, LA; Safranek, S | 1 |
Kratochvil, CJ; Lake, M; Pliszka, SR; Walkup, JT | 1 |
Pritchard, D | 2 |
Mendhekar, DN | 1 |
Cortese, S; Konofal, E; Lecendreux, M; Mouren, MC | 1 |
Cummins, TK; Kratochvil, CJ; Martin, A; Varley, C | 1 |
Benarroch, F; Gross-Tsur, V; Jaworowski, S | 1 |
Harpin, V; Jamdar, S; Poole, L; Prasad, S; Puvanendran, K; Zeitlin, H | 1 |
Bukstein, OG; Daviss, WB; McDERMOTT, MP; Palumbo, DR; Pelham, WE; Sallee, FR | 1 |
Bukstein, OG; Daviss, WB; Harris, P; McDERMOTT, MP; Palumbo, D; Patel, NC; Pelham, WE; Robb, AS; Sallee, FR | 1 |
Ghanizadeh, A | 1 |
Bukstein, O; Cannon, M; Daviss, WB; Palumbo, DR; Pelham, WH; Sallee, FR | 1 |
Kratochvil, CJ; May, DE | 1 |
Sallee, FR | 1 |
Findling, RL; Rowles, BM | 1 |
Brams, M; Findling, RL; Jain, R; Khayrallah, M; Kollins, SH; Segal, S; Wigal, SB | 1 |
Bidwell, LC; Kollins, SH; McClernon, FJ | 1 |
Hadijikoumi, I; Keen, D | 1 |
Baier, AR; Coons, EE; Fingesten, A; Ockert, DM; Volpicelli, JR | 1 |
Pattij, T; Schetters, D; Schoffelmeer, AN; van Gaalen, MM | 1 |
Cavanna, AE; Rickards, H; Worrall, R | 1 |
De Benedictis, L; Dumais, A; Landry, P | 1 |
Chung, K; Duong, S; Wigal, SB | 1 |
Childress, AC; Sallee, FR | 1 |
Pringsheim, T | 1 |
Banaschewski, T; Buitelaar, J; Coghill, D; Cortese, S; Danckaerts, M; Dittmann, RW; Graham, J; Holtmann, M; Sergeant, J; Taylor, E | 1 |
Calleja-Pérez, B; Fernández-Jaén, A; Fernández-Perrone, AL; López-Arribas, S; Martín Fernández-Mayoralas, D; Muñoz-Jareño, N | 1 |
Castells, X; Ehimare, UP; Otasowie, J; Smith, CH | 1 |
Heitzer, AM; Nawrocki, L; Roth, AK; Valdovinos, MG; Wrenn, CC | 1 |
Chan, E; Fogler, JM; Hammerness, PG | 1 |
Gao, J; He, S; Li, Y; Wang, Q; Zhang, Y | 1 |
Jain, R; Katic, A | 1 |
Anderson, RH; Mattingly, GW | 1 |
Adamo, N; Atkinson, LZ; Banaschewski, T; Barbui, C; Bhatti, S; Carucci, S; Cipriani, A; Coghill, D; Cortese, S; Del Giovane, C; Hayes, AJ; Mohr-Jensen, C; Purgato, M; Shokraneh, F; Simonoff, E; Steinhausen, HC; Xia, J; Zuddas, A | 1 |
Duncan-Wiebe, G; LeRiger, M; Shukry, M; Williams, J | 1 |
Naguy, A | 1 |
Danborg, PB; Gøtzsche, PC; Simonsen, AL | 1 |
Osland, ST; Pringsheim, T; Steeves, TD | 1 |
Adamo, N; Atkinson, LZ; Banaschewski, T; Barbui, C; Carucci, S; Cipriani, A; Coghill, D; Cortese, S; Del Giovane, C; Hayes, AJ; Hollis, C; Mohr-Jensen, C; Purgato, M; Shokraneh, F; Simonoff, E; Steinhausen, HC; Tessari, L; Xia, J; Zuddas, A | 1 |
Alamiri, B; Elsori, D; Naguy, A | 1 |
Miller, J; Perera, B; Shankar, R | 1 |
Coghill, D; Cortese, S; Newcorn, JH | 1 |
Paric, A; Patterson, B; Pipe, A; Ravindran, AV; Ravindran, N; Van Ameringen, M | 1 |
Buunk, AM; de Boer-Veger, NJ; Deneer, VHM; Guchelaar, HJ; Houwink, EJF; Jama, WOM; Nijenhuis, M; Risselada, A; Rongen, GA; Soree, B; Swen, JJ; Touw, D; van der Weide, J; van Schaik, RHN; van Westrhenen, R | 1 |
Bang Madsen, K; Bergink, V; Dreier, JW; Groth, JB; Hove Thomsen, P; Kildegaard, H; Larsson, H; Liu, X; Momen, N; Munk-Olsen, T; Newcorn, JH; Robakis, TK | 1 |
Hu, B; Huang, XH; Wang, GL; Yuan, Y; Zeng, KD; Zhang, W | 1 |
Al-Dahna, T; Dinges, HC; Eberhart, L; Rücker, G; Schubert, AK; Wiesmann, T; Wulf, H | 1 |
42 review(s) available for clonidine and methylphenidate
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacologic treatment of attention deficit hyperactivity disorder.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Clonidine; Desipramine; Female; Humans; Male; Methylphenidate | 1992 |
Clonidine in attention deficit hyperactivity disorder.
Topics: Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Child; Child, Preschool; Clonidine; Dextroamphetamine; Female; Humans; Male; Methylphenidate | 1992 |
[Children with attention deficit disorders with hyperactivity; the role of drugs in treatment].
Topics: Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Clonidine; Female; Humans; Male; Mental Processes; Methylphenidate; Neuropsychological Tests | 1991 |
Catecholamines and attention. II: Pharmacological studies in normal humans.
Topics: Adolescent; Adult; Attention; Catecholamines; Clonidine; Dose-Response Relationship, Drug; Droperidol; Humans; Male; Methylphenidate | 1987 |
Disruptive behavior, hyperactivity, and learning disabilities in children with Tourette's syndrome.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Child; Child Behavior Disorders; Clonidine; Comorbidity; Dextroamphetamine; Guanfacine; Humans; Learning Disabilities; Methylphenidate; Pemoline; Selegiline; Tourette Syndrome | 1995 |
[Attention deficit disorder with hyperactivity].
Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Child; Child, Preschool; Clonidine; Humans; Hyperkinesis; Methylphenidate; Prognosis | 1994 |
Antidepressants in the treatment of attention-deficit/hyperactivity disorder.
Topics: Adolescent; Adult; Age Factors; Antidepressive Agents; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Cognitive Behavioral Therapy; Combined Modality Therapy; Dextroamphetamine; Guanfacine; Humans; Methamphetamine; Methylphenidate; Monoamine Oxidase Inhibitors; Selective Serotonin Reuptake Inhibitors | 1997 |
Aggressive behavior in patients with attention-deficit/hyperactivity disorder, conduct disorder, and pervasive developmental disorders.
Topics: Adolescent; Aggression; Attention Deficit Disorder with Hyperactivity; Carbamazepine; Child; Child Development Disorders, Pervasive; Clinical Trials as Topic; Clomipramine; Clonidine; Conduct Disorder; Humans; Lithium; Methylphenidate; Psychotropic Drugs; Treatment Outcome | 1999 |
The Conners' Parent Rating Scales: a critical review of the literature.
Topics: Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child Behavior Disorders; Clonidine; Female; Humans; Male; Methylphenidate; Parents; Randomized Controlled Trials as Topic; Surveys and Questionnaires | 2001 |
Attention deficit hyperactivity disorder in children.
Topics: Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Central Nervous System Stimulants; Child; Clonidine; Combined Modality Therapy; Dextroamphetamine; Humans; Methylphenidate; Randomized Controlled Trials as Topic; Treatment Outcome | 2002 |
The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry.
Topics: Acetylcholine; Adrenergic alpha-Agonists; Amphetamine; Animals; Attention; Behavior, Animal; Brain; Brain Chemistry; Choice Behavior; Clonidine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Haloperidol; Methylphenidate; Norepinephrine; Psychomotor Performance; Reaction Time; Serotonin | 2002 |
Attention deficit hyperactivity disorder in children.
Topics: Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Central Nervous System Stimulants; Child; Clonidine; Combined Modality Therapy; Dextroamphetamine; Humans; Methylphenidate | 2002 |
Attention deficit hyperactivity disorder.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Combined Modality Therapy; Dextroamphetamine; Female; Humans; Male; Methylphenidate; Psychotherapy | 2003 |
Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder.
Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Child; Clonidine; Delayed-Action Preparations; Evidence-Based Medicine; Guanfacine; Humans; Methylphenidate; Propylamines | 2004 |
Pharmacological management of attention-deficit hyperactivity disorder.
Topics: Adrenergic alpha-Agonists; Amphetamines; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Child; Clonidine; Guanfacine; Humans; Methylphenidate; Propylamines | 2004 |
Pharmacologic management of behavioral instability in medically ill pediatric patients.
Topics: Adolescent; Adrenergic alpha-Agonists; Aggression; Analgesics, Non-Narcotic; Behavior Therapy; Behavioral Medicine; Benzodiazepines; Carbamazepine; Central Nervous System Stimulants; Child; Clonidine; Diphenhydramine; Histamine H1 Antagonists; Humans; Lithium; Methylphenidate; Psychomotor Agitation; Valproic Acid | 2004 |
Clinical inquiries. What is the most effective treatment for ADHD in children?
Topics: Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Central Nervous System Stimulants; Child; Child Behavior; Clonidine; Humans; Methylphenidate; Sympatholytics | 2005 |
Pharmacological management of treatment-induced insomnia in ADHD.
Topics: Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Cyproheptadine; Dose-Response Relationship, Drug; Female; Humans; Methylphenidate; Serotonin Antagonists; Sleep Initiation and Maintenance Disorders | 2005 |
Attention deficit hyperactivity disorder in children.
Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Combined Modality Therapy; Dextroamphetamine; Humans; Methylphenidate; Propylamines; Psychotherapy | 2005 |
Attention deficit hyperactivity disorder in children.
Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Combined Modality Therapy; Dextroamphetamine; Humans; Methylphenidate; Propylamines; Psychotherapy | 2006 |
The role of alpha2-adrenergic agonists in attention-deficit/hyperactivity disorder.
Topics: Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Clinical Trials as Topic; Clonidine; Delayed-Action Preparations; Drug Therapy, Combination; Electrocardiography; Guanfacine; Humans; Methylphenidate | 2010 |
Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders.
Topics: Adolescent; Amphetamines; Antipsychotic Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child Development Disorders, Pervasive; Child, Preschool; Clinical Trials as Topic; Clonidine; Comorbidity; Developmental Disabilities; Drug Therapy, Combination; Female; Fetal Alcohol Spectrum Disorders; Humans; Intellectual Disability; Male; Methylphenidate; Pregnancy; Propylamines; Psychotropic Drugs | 2010 |
Another extended-release α2-agonist for ADHD.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Delayed-Action Preparations; Humans; Methylphenidate | 2011 |
Cognitive enhancers for the treatment of ADHD.
Topics: Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Cholinergic Agents; Clonidine; Cognition; Executive Function; Guanfacine; Humans; Intelligence; Methylphenidate; Nootropic Agents; Propylamines; Reward; Social Behavior | 2011 |
ADHD in children and adolescents.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Humans; Methylphenidate; Schools | 2011 |
Metabolic, toxicological, and safety considerations for drugs used to treat ADHD.
Topics: Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Clinical Trials as Topic; Clonidine; Comorbidity; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Guanfacine; Humans; Methylphenidate; Propylamines | 2012 |
Revisiting clonidine: an innovative add-on option for attention-deficit/hyperactivity disorder.
Topics: Adolescent; Adrenergic alpha-Agonists; Amphetamine; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Central Nervous System Stimulants; Child; Clonidine; Drug Therapy, Combination; Electrocardiography; Humans; Methylphenidate; Randomized Controlled Trials as Topic | 2012 |
Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Body Size; Cardiovascular Diseases; Central Nervous System Stimulants; Child; Clonidine; Dextroamphetamine; Growth Disorders; Guanfacine; Heart Rate; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Propylamines; Psychoses, Substance-Induced; Seizures; Sleep Wake Disorders; Substance-Related Disorders; Suicide Prevention; Tic Disorders; Treatment Outcome | 2013 |
[Autism and attention deficit hyperactivity disorder: pharmacological intervention].
Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Brain; Central Nervous System Stimulants; Child; Child Development Disorders, Pervasive; Clonidine; Dopamine Uptake Inhibitors; Drug Evaluation; Guanfacine; Humans; Methylphenidate; Neuroimaging; Propylamines; Psychotropic Drugs; Randomized Controlled Trials as Topic; Treatment Outcome | 2013 |
Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Desipramine; Humans; Methylphenidate; Randomized Controlled Trials as Topic; Tic Disorders; Tourette Syndrome | 2014 |
Treatment of Attention-Deficit/Hyperactivity Disorder in Adolescents: A Systematic Review.
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Clonidine; Delayed-Action Preparations; Guanfacine; Humans; Methylphenidate; Motivation; Psychotherapy; Randomized Controlled Trials as Topic; Social Skills | 2016 |
An Evaluation on the Efficacy and Safety of Treatments for Attention Deficit Hyperactivity Disorder in Children and Adolescents: a Comparison of Multiple Treatments.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Dextroamphetamine; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Lisdexamfetamine Dimesylate; Male; Methylphenidate; Treatment Outcome | 2017 |
Current and Investigational Medication Delivery Systems for Treating Attention-Deficit/Hyperactivity Disorder.
Topics: Adrenergic Agents; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Clinical Trials as Topic; Clonidine; Guanfacine; Humans; Methylphenidate; Treatment Outcome | 2016 |
Optimizing outcomes in ADHD treatment: from clinical targets to novel delivery systems.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Anxiety Disorders; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Central Nervous System Stimulants; Clonidine; Comorbidity; Delayed-Action Preparations; Depressive Disorder; Dextroamphetamine; Guanfacine; Humans; Methylphenidate | 2016 |
Impaired reproduction after exposure to ADHD drugs: Systematic review of animal studies.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Clonidine; Female; Male; Methylphenidate; Reproduction | 2017 |
Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Clonidine; Desipramine; Dextroamphetamine; Female; Guanfacine; Humans; Male; Methylphenidate; Randomized Controlled Trials as Topic; Selegiline; Tic Disorders | 2018 |
Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis.
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Adult; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Child; Clonidine; Dose-Response Relationship, Drug; Humans; Methylphenidate; Network Meta-Analysis; Randomized Controlled Trials as Topic | 2018 |
Clinical guidance on pharmacotherapy for the treatment of attention-deficit hyperactivity disorder (ADHD) for people with intellectual disability.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Cognition; Dextroamphetamine; Humans; Intellectual Disability; Methylphenidate; Practice Guidelines as Topic; Quality of Life; Randomized Controlled Trials as Topic; Treatment Outcome | 2020 |
A Practical, Evidence-informed Approach to Managing Stimulant-Refractory Attention Deficit Hyperactivity Disorder (ADHD).
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Clonidine; Dextroamphetamine; Drug Resistance; Empirical Research; Humans; Methylphenidate; Randomized Controlled Trials as Topic | 2021 |
Treatments for child and adolescent attention deficit hyperactivity disorder in low and middle-income countries: A narrative review.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Clonidine; Developing Countries; Humans; Methylphenidate | 2022 |
Pharmacologic interventions for the therapy of postanesthetic shivering in adults: a systematic review and network meta-analysis.
Topics: Adult; Clonidine; Doxapram; Humans; Meperidine; Methylphenidate; Nefopam; Network Meta-Analysis; Shivering; Tramadol | 2023 |
13 trial(s) available for clonidine and methylphenidate
Article | Year |
---|---|
[The therapy of postoperative shivering: comparison of drugs].
Topics: Anesthesia Recovery Period; Clonidine; Humans; Meperidine; Methylphenidate; Shivering | 1991 |
Role of monoamine pathways in attention and effort: effects of clonidine and methylphenidate in normal adult humans.
Topics: Adolescent; Adult; Attention; Biogenic Amines; Clonidine; Hemodynamics; Humans; Male; Methylphenidate | 1986 |
The therapeutic effect of clonidine in attention deficit disorder with hyperactivity: a comparison with placebo and methylphenidate.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Clinical Trials as Topic; Clonidine; Double-Blind Method; Humans; Methylphenidate; Random Allocation | 1986 |
Clonidine therapy for comorbid attention deficit hyperactivity disorder and conduct disorder: preliminary findings in a children's inpatient unit.
Topics: Attention Deficit Disorder with Hyperactivity; Blood Pressure; Child; Child Behavior Disorders; Child, Hospitalized; Clonidine; Dextroamphetamine; Humans; Male; Methylphenidate; Retrospective Studies | 1994 |
The effect of methylphenidate and clonidine on response inhibition and state regulation in children with ADHD.
Topics: Arousal; Attention; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Double-Blind Method; Drug Resistance; Female; Humans; Inhibition, Psychological; Male; Methylphenidate; Multivariate Analysis; Neuropsychological Tests; Pattern Recognition, Visual; Perceptual Masking; Reaction Time; Sympatholytics; Time Factors; Volition | 1999 |
Tryptophan depletion impairs stimulus-reward learning while methylphenidate disrupts attentional control in healthy young adults: implications for the monoaminergic basis of impulsive behaviour.
Topics: Adolescent; Adrenergic Agents; Adult; Attention; Clonidine; Discrimination Learning; Double-Blind Method; Female; Humans; Impulsive Behavior; Male; Methylphenidate; Reward; Tryptophan | 1999 |
A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder.
Topics: Adolescent; Adrenergic alpha-Agonists; Aggression; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Conduct Disorder; Confounding Factors, Epidemiologic; Double-Blind Method; Drug Therapy, Combination; Humans; Male; Methylphenidate; Pilot Projects; Psychiatric Status Rating Scales; Psychomotor Performance; Treatment Outcome | 2000 |
Treatment of ADHD in children with tics: a randomized controlled trial.
Topics: Adolescent; Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Confidence Intervals; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Methylphenidate; Surveys and Questionnaires; Tic Disorders; Treatment Outcome | 2002 |
A multi-centre, randomised, open-label study of atomoxetine compared with standard current therapy in UK children and adolescents with attention-deficit/hyperactivity disorder (ADHD).
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Drug Therapy, Combination; Female; Headache; Humans; Male; Methylphenidate; Nausea; Propylamines; Prospective Studies; Severity of Illness Index; Treatment Outcome | 2007 |
Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes.
Topics: Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Methylphenidate; Personality Assessment; Social Environment; Treatment Outcome | 2008 |
Clonidine for attention-deficit/hyperactivity disorder: II. ECG changes and adverse events analysis.
Topics: Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Bradycardia; Central Nervous System Stimulants; Child; Clonidine; Double-Blind Method; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Electrocardiography; Female; Heart Rate; Humans; Long QT Syndrome; Male; Methylphenidate; Personality Assessment; Sleep Stages; Tachycardia | 2008 |
Effects of clonidine and methylphenidate on family quality of life in attention-deficit/hyperactivity disorder.
Topics: Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Double-Blind Method; Drug Therapy, Combination; Family Health; Female; Humans; Linear Models; Male; Methylphenidate; Psychiatric Status Rating Scales; Quality of Life | 2009 |
Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD.
Topics: Adolescent; Adolescent Behavior; Adrenergic alpha-2 Receptor Agonists; Amphetamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child Behavior; Clonidine; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Methylphenidate; Retrospective Studies; Treatment Outcome | 2011 |
52 other study(ies) available for clonidine and methylphenidate
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Antistereotype effects of ceruletide and some neuroleptics differentiated by interactions with clonazepam, muscimol, scopolamine and clonidine.
Topics: Animals; Antipsychotic Agents; Ceruletide; Clonazepam; Clonidine; Clopenthixol; Fluphenazine; Haloperidol; Male; Methylphenidate; Mice; Muscimol; Scopolamine; Sincalide; Stereotyped Behavior | 1986 |
Tourette's syndrome in Monroe County school children.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Behavior; Child; Child, Preschool; Clonidine; Female; Haloperidol; Humans; Male; Methylphenidate; Motor Activity; Movement Disorders; Nervous System Diseases; New York; Obsessive-Compulsive Disorder; Tic Disorders; Tourette Syndrome | 1988 |
Electrophysiological effects of methylphenidate on the coeruleo-cortical noradrenergic system in the rat.
Topics: Animals; Behavior, Animal; Clonidine; Desipramine; Electric Stimulation; Electrophysiology; Iontophoresis; Locus Coeruleus; Male; Methylphenidate; Neurons; Norepinephrine; Rats; Rats, Inbred Strains | 1988 |
Treatment effects of oral and transdermal clonidine in relation to methylphenidate: an open pilot study in ADD-H.
Topics: Administration, Cutaneous; Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Female; Humans; Male; Methylphenidate; Pilot Projects | 1987 |
Studies of various amphetamines, apomorphine and clonidine on body temperature and brain 5-hydroxytryptamine metabolism in rats.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Body Temperature; Brain; Brain Chemistry; Carboxylic Acids; Chromatography, Ion Exchange; Clonidine; Fever; Hydroxyindoleacetic Acid; Male; Methylphenidate; Naphthyridines; Phenmetrazine; Piperidines; Rats; Serotonin; Spectrometry, Fluorescence; Temperature | 1974 |
Strategies for study of the neurochemistry of attention deficit disorder in children.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Dopamine beta-Hydroxylase; Growth Hormone; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Methylphenidate; Monoamine Oxidase; Neurotransmitter Agents; Prolactin; Serotonin; Tyrosine 3-Monooxygenase | 1982 |
Possible change in noradrenergic receptor sensitivity following methylphenidate treatment: growth hormone and MHPG response to clonidine challenge in children with attention deficit disorder and hyperactivity.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Child Behavior; Clonidine; Drug Interactions; Drug Tolerance; Epinephrine; Glycols; Growth Hormone; Humans; Male; Methoxyhydroxyphenylglycol; Methylphenidate; Norepinephrine; Time Factors | 1984 |
Clonidine and sudden death.
Topics: Child; Clonidine; Death, Sudden, Cardiac; Drug Therapy, Combination; Female; Humans; Male; Methylphenidate | 1995 |
Pediatricians' knowledge and attitudes concerning diagnosis and treatment of attention deficit and hyperactivity disorders. A national survey approach.
Topics: Adult; Aged; Amphetamines; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Clinical Competence; Clonidine; Cross-Sectional Studies; Female; Health Education; Humans; Male; Methylphenidate; Middle Aged; Pediatrics; Pemoline; Sampling Studies | 1995 |
Combined pharmacotherapy: an emerging trend in pediatric psychopharmacology.
Topics: Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Benzodiazepines; Child Psychiatry; Clomipramine; Clonidine; Depressive Disorder; Drug Therapy, Combination; Humans; Methylphenidate; Psychopharmacology; Psychotic Disorders; Tic Disorders | 1995 |
Methylphenidate-induced hepatotoxicity in mice and its potentiation by beta-adrenergic agonist drugs.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Alanine Transaminase; Animals; Clonidine; Drug Synergism; Female; Liver; Male; Methylphenidate; Mice; Mice, Inbred ICR; Necrosis; Phenylephrine | 1994 |
Attention deficit hyperactivity disorder in adults: diagnosis, treatment, and prognosis.
Topics: Adult; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Clonidine; Dextroamphetamine; Diagnosis, Differential; Humans; Methylphenidate; Physical Examination; Prognosis; Psychological Tests; Psychotropic Drugs; Social Support | 1994 |
Clonidine for stimulant-related sleep problems.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Dextroamphetamine; Drug Therapy, Combination; Humans; Learning Disabilities; Male; Methylphenidate; Sleep Initiation and Maintenance Disorders | 1994 |
Clonidine and electrocardiograms.
Topics: Adult; Child; Clonidine; Drug Interactions; Electrocardiography; Humans; Hypertension; Methylphenidate; Substance Withdrawal Syndrome | 1996 |
Clonidine for treatment of attention-deficit/hyperactivity disorder.
Topics: Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Central Nervous System; Central Nervous System Stimulants; Child; Child, Preschool; Clonidine; Controlled Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Humans; Methylphenidate | 1996 |
Safety of combined pharmacotherapy.
Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Child; Child Psychiatry; Clonidine; Drug Interactions; Fetal Alcohol Spectrum Disorders; Humans; Methylphenidate | 1997 |
Effects of alpha-2 adrenoceptor agonists and antagonists on circling behavior in rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Apomorphine; Behavior, Animal; Benzofurans; Brimonidine Tartrate; Clonidine; Dopamine Agonists; Idazoxan; Imidazoles; Ligands; Male; Methylphenidate; Oxidopamine; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Stereoisomerism; Stereotyped Behavior; Substantia Nigra | 1999 |
Combining methylphenidate and clonidine: a clinically sound medication option.
Topics: Adolescent; Adverse Drug Reaction Reporting Systems; Aggression; Antihypertensive Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child Welfare; Clonidine; Drug Interactions; Drug Therapy, Combination; Humans; Methylphenidate; Safety | 1999 |
Clonidine and methylphenidate.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Fatal Outcome; Female; Humans; Male; Methylphenidate; Sympatholytics | 1999 |
Psychotropic drug use rising among preschoolers.
Topics: Antidepressive Agents; Central Nervous System Stimulants; Child Health Services; Child, Preschool; Clonidine; Humans; Medicaid; Methylphenidate; Practice Patterns, Physicians'; Psychotropic Drugs; United States | 2000 |
Drugged-out toddlers. A new study documents an alarming increase in behavior-altering medication for preschoolers.
Topics: Age Factors; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child, Preschool; Clonidine; Female; Humans; Male; Methylphenidate; Practice Patterns, Physicians'; Sympatholytics; United States | 2000 |
[Attention deficit disorder with hyperactivity in children: diagnosis and therapeutic management].
Topics: Adolescent; Adrenergic alpha-Agonists; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clinical Trials as Topic; Clonidine; Diagnosis, Differential; Double-Blind Method; Humans; Methylphenidate; Psychotherapy; Surveys and Questionnaires; Sympathomimetics | 2000 |
[Functioning, comorbidity and treatment of 141 adults with attention deficit hyperactivity disorder (ADHD) at a psychiatric outpatient department].
Topics: Adrenergic alpha-Agonists; Adult; Age Factors; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Clonidine; Comorbidity; Diagnosis, Differential; Female; Humans; Male; Mental Disorders; Methylphenidate; Middle Aged; Netherlands; Retrospective Studies | 2001 |
Use of medication by young people with attention-deficit/hyperactivity disorder.
Topics: Adolescent; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Australia; Central Nervous System Stimulants; Child; Clonidine; Dexamethasone; Humans; Interviews as Topic; Methylphenidate; Psychotropic Drugs; Substance-Related Disorders; Surveys and Questionnaires | 2002 |
Genetics of childhood disorders: XLIV. autism, part 3: psychopharmacology of autism.
Topics: Adrenergic alpha-Agonists; Autistic Disorder; Central Nervous System Stimulants; Clonidine; Humans; Methylphenidate; Serotonin | 2002 |
Ritalin is okay for kids with both ADHD and Tourette's syndrome, study says.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clinical Trials as Topic; Clonidine; Drug Therapy, Combination; Humans; Methylphenidate; Practice Guidelines as Topic; Tourette Syndrome; Treatment Outcome; United States | 2002 |
Effects of methylphenidate on the inhibitory postsynaptic potential in rat locus coeruleus neurons.
Topics: Animals; Clonidine; Evoked Potentials; Excitatory Postsynaptic Potentials; Humans; In Vitro Techniques; Locus Coeruleus; Male; Methylphenidate; Rats; Rats, Wistar; Synaptic Transmission | 2002 |
Methylphenidate an effective treatment for ADHD?
Topics: Adrenergic alpha-Agonists; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Central Nervous System Stimulants; Child; Child Development Disorders, Pervasive; Clonidine; Diagnostic Errors; Guanfacine; Humans; Male; Medication Errors; Methylphenidate; Risperidone | 2004 |
Clonidine-induced gynecomastia and hyperprolactinemia in a 6-year-old child.
Topics: Age Factors; Anticonvulsants; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Comorbidity; Gynecomastia; Humans; Hyperprolactinemia; Male; Methylphenidate; Seizures; Valproic Acid | 2005 |
ADHD and insomnia.
Topics: Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Cyproheptadine; Female; Humans; Methylphenidate; Restless Legs Syndrome; Serotonin Antagonists; Sleep Wake Disorders | 2006 |
Less is more: inpatient management of a child with complex pharmacotherapy.
Topics: Aggression; Amphetamines; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Depression; Dibenzothiazepines; Domestic Violence; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Humans; Irritable Mood; Length of Stay; Male; Methylphenidate; Patient Admission; Psychiatric Department, Hospital; Psychomotor Agitation; Psychotropic Drugs; Quetiapine Fumarate; Recurrence; Sertraline; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Valproic Acid | 2006 |
Concomitant use of atomoxetine and OROS-methylphenidate in a 10-year-old child suffering from attention-deficit/hyperactivity disorder with comorbid bipolar disorder and Tourette syndrome.
Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Central Nervous System Stimulants; Child; Clonidine; Comorbidity; Drug Therapy, Combination; Humans; Male; Methylphenidate; Propylamines; Tics; Tourette Syndrome | 2006 |
Insomnia, night terror, and depression related to clonidine in attention-deficit/hyperactivity disorder.
Topics: Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Depression; Drug Therapy, Combination; Humans; Male; Methylphenidate; Night Terrors; Sleep Initiation and Maintenance Disorders | 2008 |
Attention-deficit hyperactivity disorder: recent advances in paediatric pharmacotherapy.
Topics: Administration, Oral; Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Dexmethylphenidate Hydrochloride; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Approval; Drug Therapy, Combination; Half-Life; Health Care Costs; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Pediatrics; Prodrugs; Propylamines; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Treatment Outcome | 2010 |
A nonopioid procedure for outpatient opioid detoxification.
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Adult; Benzhydryl Compounds; Central Nervous System Stimulants; Clonidine; Drug Therapy, Combination; Female; GABA Modulators; Heroin Dependence; Humans; Lorazepam; Male; Methylphenidate; Middle Aged; Modafinil; New York; Opioid-Related Disorders; Outpatients; Selective Serotonin Reuptake Inhibitors; Substance Abuse Treatment Centers; Trazodone; Treatment Outcome; Young Adult | 2011 |
On the improvement of inhibitory response control and visuospatial attention by indirect and direct adrenoceptor agonists.
Topics: Adrenergic Agonists; Animals; Attention; Choice Behavior; Clenbuterol; Clonidine; Desipramine; Dobutamine; Dose-Response Relationship, Drug; Inhibition, Psychological; Isoproterenol; Male; Methylphenidate; Phenylephrine; Rats; Rats, Wistar; Reaction Time; Serial Learning | 2012 |
Treatment practices in Tourette syndrome: the European perspective.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Depression; Europe; Fluoxetine; Fluvoxamine; Health Care Surveys; Humans; Methylphenidate; Obsessive-Compulsive Disorder; Physicians; Piperazines; Propylamines; Psychiatry; Quinolones; Risperidone; Sertraline; Sulpiride; Tourette Syndrome | 2012 |
Successful treatment of severe disruptive disorder featuring symptoms of the Klüver-Bucy Syndrome following a massive right temporal-parietal hemorrhage.
Topics: Adrenergic alpha-Agonists; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cerebral Angiography; Clonidine; Coma; Electroencephalography; Female; Humans; Intracranial Hemorrhages; Kluver-Bucy Syndrome; Methylphenidate; Neuropsychological Tests; Parietal Lobe; Sexual Behavior; Stroke; Temporal Lobe; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Young Adult | 2013 |
Psychopharmacology for the clinician: management of comorbid Tourette syndrome and attention-deficit/hyperactivity disorder: are psychostimulants an option?
Topics: Adrenergic alpha-2 Receptor Agonists; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Comorbidity; Humans; Male; Methylphenidate; Tics; Tourette Syndrome; Treatment Outcome | 2012 |
Effects of clonidine and methylphenidate on motor activity in Fmr1 knockout mice.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Clonidine; Fragile X Mental Retardation Protein; Fragile X Syndrome; Methylphenidate; Mice, Knockout; Motor Activity | 2015 |
Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis.
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Adult; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Child; Clinical Protocols; Clonidine; Dose-Response Relationship, Drug; Humans; Methylphenidate; Network Meta-Analysis; Treatment Outcome | 2017 |
Acute masseter dystonia in a pediatric patient receiving aripiprazole and methylphenidate following induction of general anesthesia.
Topics: Anesthesia, General; Antipsychotic Agents; Appendectomy; Aripiprazole; Central Nervous System Stimulants; Child; Clonidine; Diphenhydramine; Dystonia; Histamine H1 Antagonists; Humans; Male; Methylphenidate; Trismus | 2017 |
Pharmacotherapy of Attention Deficit Hyperactivity Disorder Symptom Profile in ASD.
Topics: Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Comorbidity; Cross-Sectional Studies; Guanfacine; Humans; Methylphenidate; Randomized Controlled Trials as Topic; Risperidone; Social Adjustment; Treatment Outcome | 2017 |
Methylphenidate-Induced Nocturnal Bruxism Alleviated by Adjunctive Clonidine.
Topics: Analgesics; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Drug Therapy, Combination; Female; Humans; Jordan; Methylphenidate; Sleep Bruxism | 2019 |
Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction of CYP2D6 and COMT with atomoxetine and methylphenidate.
Topics: Atomoxetine Hydrochloride; Catechol O-Methyltransferase; Clonidine; Cytochrome P-450 CYP2D6; Drug Interactions; Humans; Methylphenidate; Pharmacogenetics | 2023 |
In utero exposure to ADHD medication and long-term offspring outcomes.
Topics: Adult; Amphetamines; Attention Deficit Disorder with Hyperactivity; Child, Preschool; Clonidine; Cohort Studies; Denmark; Female; Gestational Age; Humans; Infant; Methylphenidate; Modafinil; Mothers; Neurodevelopmental Disorders; Pregnancy; Prenatal Exposure Delayed Effects; Registries | 2023 |
Efficacy of clonidine in the treatment of children with tic disorder co-morbid with attention deficit hyperactivity disorder.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Haloperidol; Humans; Methylphenidate; Tic Disorders; Tics; Treatment Outcome | 2023 |